erythrosine has been researched along with Retrolental Fibroplasia in 22 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thalidomide is a well-known anti-angiogenic drug." | 5.35 | The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity. ( Katz, G; Pri-Chen, S; Rabinowitz, R; Rosner, M; Spierer, A, 2008) |
| "Animals that received ibuprofen during hyperoxia exposure had a significantly lower median (25th, 75th quartile) retinopathy score of 6 (5, 7." | 3.72 | Ibuprofen improves oxygen-induced retinopathy in a mouse model. ( Barr, SM; Geng, Y; Higgins, RD; Sharma, J; Yun, Y, 2003) |
| "Retinal neovascularization was observed by fluorescence angiography and was quantified by counting the endothelial nuclei protruding into the vitreous cavity after hematoxylin-eosin staining." | 1.37 | Netrin-1 overexpression in oxygen-induced retinopathy correlates with breakdown of the blood-retina barrier and retinal neovascularization. ( Jiang, J; Liu, D; Liu, JL; Tian, XF; Xia, XB; Xiong, SQ, 2011) |
| "Retinal neovascularization was evaluated by angiography with injection of fluorescein-dextran and quantification of neovascular proliferative retinopathy after 5 days in room air." | 1.35 | Suppression of retinal neovascularization by small-interference RNA targeting erythropoietin. ( Jiang, J; Xia, XB; Xiong, SQ; Xu, HZ, 2009) |
| "Thalidomide is a well-known anti-angiogenic drug." | 1.35 | The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity. ( Katz, G; Pri-Chen, S; Rabinowitz, R; Rosner, M; Spierer, A, 2008) |
| "Riluzole is a Food and Drug Administration-approved anti-ALS drug with a favorable adverse effect profile." | 1.34 | Insulin increases retinal hemorrhage in mild oxygen-induced retinopathy in the rat: inhibition by riluzole. ( Cho, KS; Chung, H; Koh, JY; Yoo, MH; Yoon, YH, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.09) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 8 (36.36) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Gonzalez, A | 1 |
| Agarwal-Sinha, S | 1 |
| Chen, X | 1 |
| Mangalesh, S | 1 |
| Tran-Viet, D | 1 |
| Freedman, SF | 1 |
| Vajzovic, L | 1 |
| Toth, CA | 1 |
| Blair, MP | 1 |
| Hilkert Rodriguez, S | 1 |
| Chan, RVP | 1 |
| Shapiro, MJ | 1 |
| Lepore, D | 1 |
| Ji, MH | 1 |
| Quinn, G | 1 |
| Bai, YJ | 1 |
| Huang, LZ | 1 |
| Zhou, AY | 1 |
| Zhao, M | 1 |
| Yu, WZ | 1 |
| Li, XX | 1 |
| Dal Monte, M | 1 |
| Ristori, C | 1 |
| Cammalleri, M | 1 |
| Bagnoli, P | 1 |
| Xiong, SQ | 2 |
| Xia, XB | 2 |
| Xu, HZ | 1 |
| Jiang, J | 2 |
| Tian, XF | 1 |
| Liu, D | 1 |
| Liu, JL | 1 |
| Newman, H | 1 |
| Shapira, S | 1 |
| Spierer, O | 1 |
| Kraus, S | 1 |
| Rosner, M | 3 |
| Pri-Chen, S | 3 |
| Loewenstein, A | 1 |
| Arber, N | 1 |
| Barak, A | 1 |
| Rabinowitz, R | 2 |
| Priel, A | 1 |
| Spierer, A | 2 |
| Zhang, HB | 1 |
| Sun, NX | 1 |
| Liang, HC | 1 |
| Xiao, XH | 1 |
| Liu, XN | 1 |
| Wang, YN | 1 |
| Sharma, J | 1 |
| Barr, SM | 1 |
| Geng, Y | 1 |
| Yun, Y | 1 |
| Higgins, RD | 3 |
| Yoo, MH | 1 |
| Yoon, YH | 1 |
| Chung, H | 1 |
| Cho, KS | 1 |
| Koh, JY | 1 |
| Katz, G | 1 |
| Smith, LE | 2 |
| Wesolowski, E | 2 |
| McLellan, A | 1 |
| Kostyk, SK | 1 |
| D'Amato, R | 1 |
| Sullivan, R | 1 |
| D'Amore, PA | 1 |
| Penn, JS | 1 |
| Tolman, BL | 1 |
| Bullard, LE | 1 |
| Yossuck, P | 2 |
| Yan, Y | 2 |
| Tadesse, M | 2 |
| Lonchampt, M | 1 |
| Pennel, L | 1 |
| Duhault, J | 1 |
| O'Grady, GE | 2 |
| Flynn, JT | 2 |
| Herrera, JA | 2 |
| Cantolino, SJ | 1 |
| Israel, C | 1 |
| Justice, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care (BabySTEPS)[NCT02887157] | 191 participants (Actual) | Observational | 2016-07-22 | Completed | |||
| Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care 2 and School Age Follow on Study (BabySTEPS2)[NCT04995341] | 236 participants (Anticipated) | Interventional | 2021-08-16 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
22 other studies available for erythrosine and Retrolental Fibroplasia
| Article | Year |
|---|---|
Fluorescein angiographic features post-intravitreal bevacizumab for retinopathy of prematurity: can they support rescue laser photocoagulation to the avascular retina.
Topics: Angiogenesis Inhibitors; Bevacizumab; Child, Preschool; Fluorescein Angiography; Fluoresceins; Gesta | 2020 |
Fluorescein Angiographic Characteristics of Macular Edema During Infancy.
Topics: Birth Weight; Blood-Retinal Barrier; Capillary Permeability; Child, Preschool; Cross-Sectional Studi | 2018 |
Fluorescein Angiographic Characteristics of Macular Edema During Infancy.
Topics: Birth Weight; Blood-Retinal Barrier; Capillary Permeability; Child, Preschool; Cross-Sectional Studi | 2018 |
Fluorescein Angiographic Characteristics of Macular Edema During Infancy.
Topics: Birth Weight; Blood-Retinal Barrier; Capillary Permeability; Child, Preschool; Cross-Sectional Studi | 2018 |
Fluorescein Angiographic Characteristics of Macular Edema During Infancy.
Topics: Birth Weight; Blood-Retinal Barrier; Capillary Permeability; Child, Preschool; Cross-Sectional Studi | 2018 |
Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226).
Topics: Bevacizumab; Fluoresceins; Follow-Up Studies; Humans; Infant, Newborn; Intravitreal Injections; Reti | 2018 |
Reply.
Topics: Bevacizumab; Fluoresceins; Follow-Up Studies; Humans; Infant, Newborn; Intravitreal Injections; Reti | 2018 |
Antiangiogenesis effects of endostatin in retinal neovascularization.
Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Apoptosis; Blotting, Western; Cell Movement; Cel | 2013 |
Effects of somatostatin analogues on retinal angiogenesis in a mouse model of oxygen-induced retinopathy: involvement of the somatostatin receptor subtype 2.
Topics: Animals; Animals, Newborn; Blotting, Western; Dextrans; Enzyme-Linked Immunosorbent Assay; Female; F | 2009 |
Suppression of retinal neovascularization by small-interference RNA targeting erythropoietin.
Topics: Animals; Animals, Newborn; Base Sequence; Blotting, Western; Cell Culture Techniques; Dextrans; Dise | 2009 |
Netrin-1 overexpression in oxygen-induced retinopathy correlates with breakdown of the blood-retina barrier and retinal neovascularization.
Topics: Animals; Blood-Retinal Barrier; Blotting, Western; Capillary Permeability; Dextrans; Disease Models, | 2011 |
Involvement of CD24 in angiogenesis in a mouse model of oxygen-induced retinopathy.
Topics: Animals; Animals, Newborn; CD24 Antigen; Dextrans; Disease Models, Animal; Fluoresceins; Humans; Hyp | 2012 |
Avastin treatment reduces retinal neovascularization in a mouse model of retinopathy of prematurity.
Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Antibodies, Monoclonal, Humanized; Bevacizumab; | 2012 |
17-Alpha-estradiol ameliorating oxygen-induced retinopathy in a murine model.
Topics: Animals; Animals, Newborn; Capillary Permeability; Dextrans; Disease Models, Animal; Dose-Response R | 2012 |
Ibuprofen improves oxygen-induced retinopathy in a mouse model.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Dextrans; Disease Models, Animal | 2003 |
Insulin increases retinal hemorrhage in mild oxygen-induced retinopathy in the rat: inhibition by riluzole.
Topics: Animals; Animals, Newborn; Blotting, Western; Dextrans; Disease Models, Animal; Enzyme-Linked Immuno | 2007 |
The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity.
Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Dextrans; Disease Models, Animal; Fluoresceins; | 2008 |
Oxygen-induced retinopathy in the mouse.
Topics: Animals; Dextrans; Disease Models, Animal; Fluorescein Angiography; Fluoresceins; Fundus Oculi; Glia | 1994 |
Effect of light on oxygen-induced retinopathy in the mouse.
Topics: Animals; Dark Adaptation; Dextrans; Disease Models, Animal; Fluorescein Angiography; Fluoresceins; F | 1994 |
Effect of a water-soluble vitamin E analog, trolox C, on retinal vascular development in an animal model of retinopathy of prematurity.
Topics: Animals; Animals, Newborn; Antioxidants; Capillaries; Chromans; Dextrans; Disease Models, Animal; Fl | 1997 |
Dexamethasone and critical effect of timing on retinopathy.
Topics: Animals; Animals, Newborn; Dexamethasone; Dextrans; Disease Models, Animal; Fluoresceins; Glucocorti | 2000 |
Hyperoxia/normoxia-driven retinal angiogenesis in mice: a role for angiotensin II.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; | 2001 |
Lack of effect of gender on retinopathy in the mouse.
Topics: Animals; Animals, Newborn; Dextrans; Disease Models, Animal; Female; Fluoresceins; Humans; Hyperoxia | 2001 |
The clinical course of retrolental fibroplasia in premature infants.
Topics: Cryosurgery; Fluoresceins; Fundus Oculi; Humans; Infant, Newborn; Oxygen Inhalation Therapy; Photogr | 1972 |
Ophthalmoscopic monitoring of oxygen therapy in premature infants. Fluorescein angiography in acute retrolental fibroplasia.
Topics: Acute Disease; Female; Fluoresceins; Fundus Oculi; Humans; Infant; Infant, Newborn; Male; Ophthalmos | 1971 |